CA
NTUS

Calton & Associates’s Natus Medical Inc NTUS Stock Holding History

Calton & Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-227
Closed -$6K – 1373
2017
Q4 		$6K Buy
+227
New +$9.06K ﹤0.01% 1221

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Calton & Associates's NTUS Position: Q1 2018 in Review

Calton & Associates sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 227 shares — an estimated $6K sold.

Calton & Associates first reported a position in NTUS in Q4 2017 and held it in 1 quarter. The position peaked at $6K in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Calton & Associates reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 227 Natus Medical Inc shares in Q1 2018, an estimated $6K.
  • Calton & Associates first reported a position in Natus Medical Inc in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Natus Medical Inc position peaked at $6K in Q4 2017.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.